ArticlePloS one2025
CT imaging biomarkers to predict severity and prognosis of pulmonary hypertension.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Genetic Determinants of Pulmonary Artery Size in over 50,000 Subjects with and without COPD.medRxiv : the preprint server for health sciences · 2026Article
- Pulmonary Artery and Vein Morphology as an Imaging Biomarker for the Diagnosis of Pulmonary Hypertension.Diagnostics (Basel, Switzerland) · 2026Article
- Developing a novel deep learning-based model for automatic right ventricular parameters assessment on ctpa in pulmonary embolism.Emergency radiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo explore whether there are computed tomography (CT) imaging biomarkers that can stratify the severity of patients with pulmonary hypertension (PH).
methodsWe retrospectively enrolled 144 consecutive patients with suspected PH who underwent CT pulmonary angiography and right heart catheterization (RHC). CT findings were analyzed by two observers for large vessel size [ascending aorta (A), pulmonary artery (P), inferior vena cava (IVC)], each chamber size, and septal angle. We investigated the associations between CT imaging parameters and the mean pulmonary artery pressure (mPAP) from RHC. During a median follow-up of 36 months, we observed major adverse cardiovascular events (MACE; all-cause mortality and hospitalization for PH worsening). Univariate and multivariate Cox regression models were used with hazard ratios (HR) and 95% confidence intervals (95% CI) to determine independent predictors of MACE in patients with PH.
resultsOf 144 patients, 116 (80.2%) were diagnosed with PH based on an mPAP of 20 mmHg. Among CT parameters, P, P/A ratio, right ventricle (RV), and RV/left ventricle (LV) ratio were strongly correlated with mPAP values (Pearson's correlation coefficient, all r < 0.001). During the follow-up period, 44 (30.6%) patients developed MACE (14 deaths and 30 hospitalizations). Using multivariate Cox regression analysis, the RV/LV ratio (HR 2.32; 95% CI: 1.17-4.59) was the best predictor of MACE, followed by age (HR 1.03, 95% CI;1.00-1.05) (all p < 0.05). Among various CT parameters, A, P, and P/A ratio showed excellent reliability with intraclass correlation coefficient ≥ 0.95.
conclusionAmong CT parameters, the RV/LV ratio was the most robust predictor of MACE in patients with PH, while the P and P/A ratios served as reliable indicators reflecting mPAP levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.